3 ASX agriculture shares just re-rated by experts

Morgans has revised its ratings and 12-month price targets on Nufarm, Graincorp, and Elders.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Nufarm Ltd (ASX: NUF): Morgans has upgraded Nufarm to a "Buy" with a price target of $3.20, following slightly better-than-guided FY25 results despite high gearing levels. The broker is optimistic about material earnings growth, reduced leverage, and improved industry conditions in FY26.
  • Elders Ltd (ASX: ELD): Retaining its "Buy" rating, Morgans is encouraged by Elders' strong growth prospects for FY26, which include a positive rainfall outlook and higher selling prices. The price target has been increased from $8.50 to $8.65, based on a solid start to 1Q26 and optimistic outlook comments.
  • Graincorp Ltd (ASX: GNC): Morgans maintains an "Accumulate" rating with a price target of $9.05, citing Graincorp's stronger-than-expected operating cash flow and attractive dividend. Despite a subdued margin environment expected in FY26, the broker highlights the company’s strong fixed cost leverage in potential future crop production scenarios.

The S&P/ASX All Ordinaries Index (ASX: XAO) is in the green on Tuesday, up 0.08% to 8,873.8 points.

Morgans has updated its ratings and 12-month price targets on three ASX agriculture shares following their FY25 reports.

Let's take a look.

happy farmer, agricultural stock rise

Image source: Getty Images

Nufarm Ltd (ASX: NUF

Nufarm is an agricultural chemical and seed-technology company with clients all over the world.

The Nufarm share price is $2.39, down 2.85% today and down 34% in the year to date.

Morgans has a buy rating on Nufarm shares with a 12-month price target of $3.20 following the company's FY25 results.

The broker commented:

While NUF's FY25 result was weak, it was slightly above guidance.

A solid Crop Protection result was overshadowed by a poor Seed Technologies performance. Gearing was far too high at 2.7x, however it was better than feared. Outlook comments were upbeat.

In FY26, material earnings growth and a reduction in leverage ratios is expected. We have upgraded our forecasts. Now that there is certainty on Seed Technologies future, industry operating conditions have improved and there is a clear pathway to deleveraging the balance sheet, we upgrade NUF to a Buy recommendation and A$3.20 price target.

Elders Ltd (ASX: ELD)

Elders supplies all types of farming products, as well as advisory, financial, and real estate services.

The Elders share price is $7.28, up 0.14% on Tuesday and up 1% for 2025.

Recently, the broker retained its buy rating on Elders after the company released its FY25 results.

Morgans says there are many drivers in FY26 that should enable Elders to deliver strong growth.

The broker upgraded its price target on the ASX agriculture share from $8.50 to $8.65.

Morgans commented:

ELD's FY25 result was in line with its guidance. As was well guided too, the 2H25 was weak due to drought.

Outlook comments were optimistic, the 1Q26 is off to a strong start and FY26 should benefit from a positive rainfall outlook, higher selling prices, acquisitions and the transformation projects.

Graincorp Ltd (ASX: GNC)

Graincorp offers grain handling, storage and logistics services, as well as trading and marketing. It also processes oilseeds to produce vegetable oils and other food products.

The Graincorp share price is $8.09, up 0.4% today and up 9.6% in the year to date.

Morgans thinks this ASX agriculture share has been oversold following an 8.4% decline over the past month.

The broker maintained an accumulate rating on Graincorp shares with a new price target of $9.05 following the company's FY25 results.

Morgans said:

While it can be argued that the FY25 P&L result was lower quality due to one-offs, operating cashflow was materially stronger than expected, underpinning GNC's strong core cash position.

This allowed the company to reward shareholders with an attractive final dividend.

In line with the recent outlook commentary from its international peers, GNC said that the margin environment will likely remain subdued in FY26. Consensus estimates were therefore too high.

Importantly, payments to the insurer will no longer occur in big crop years, allowing GNC's strong fixed cost leverage to return when crop production issues around the world ultimately eventuate.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Elders. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »

Three balls at various places on a cycle.
Broker Notes

6 ASX uranium shares to buy ahead of yellow cake rising to US$200 per pound: experts

This broker tips 83% to 295% upside over 12 months for its 6 top ASX uranium share picks.

Read more »